Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025

Illumina's PromoterAI unlocks rare disease clues in noncoding genome

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. ocks-rare-disease-clues-in-noncoding-genome.html
  Print publication without navigation Published in Science and Technology on by STAT
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
And more biotech news brought to you by The Readout.
The article from STAT News dated May 30, 2025, discusses several key developments in the biotech industry. Moderna announced promising results from its latest mRNA vaccine trials, boosting investor confidence and stock prices. Illumina faced regulatory challenges in its acquisition of Grail, with the European Commission ordering the divestiture of Grail due to antitrust concerns. Omada Health, a digital health company, secured a significant investment to expand its virtual care services. Additionally, the National Cancer Institute (NCI) released a report highlighting advancements in cancer research, particularly in immunotherapy and personalized medicine. The Maha Report provided insights into the biotech market trends, emphasizing the growing interest in gene editing technologies and the increasing role of AI in drug discovery.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/05/30/biotech-news-moderna-illumina-omada-summit-nci-maha-report/ ]


Similar Science and Technology Publications